Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 716 (USA) (Dr. Ito)
· consented 2013-04-27
Adverse events
3
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
mild
assessed
2026-08-18
Mild CONFUSIONAL STATE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-15 (study day 172.0); relationship: POSSIBLE
mild
assessed
2026-08-18
Mild DIARRHOEA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-21 (study day 25.0); relationship: POSSIBLE
mild
assessed
2026-08-18
Mild DIARRHOEA — outcome: RECOVERED/RESOLVED; onset 2013-05-21 (study day 25.0); relationship: POSSIBLE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.